Acquisition of Verttec

Zotefoams acquires Verttec for up to US$7.3m, gaining US crosslinked roll foam capability.

What the company is saying

Zotefoams plc (LSE:ZTF) announces the acquisition of Verttec LLC, a Pennsylvania-based technical roll foam manufacturer, for up to US$7.3m. The company frames this as a strategic move to extend its product range for North American converter customers and to add a specialist crosslinked roll foam capability previously absent from its portfolio. The release emphasizes that replicating Verttec organically would have cost US$20m and taken five years, positioning the acquisition as a faster, lower-risk, and more cost-effective route. Management highlights Verttec’s in-house developed process, established customer base, and significant spare capacity as key assets. CEO Ronan Cox and Verttec President Ryan Dempsey are both quoted, stressing the complementary nature of the acquisition and the growth opportunities it brings. The announcement is confident in tone, but it downplays near-term financial impact, stating the contribution to 2026 revenue will be modest and full-year expectations remain unchanged.

What the data suggests

The acquisition price is up to US$7.3m, with US$5.1m paid at closing and up to US$2.2m contingent on Verttec’s revenue and performance over 24 months. Verttec reported US$5.1m in revenue and US$0.3m in adjusted EBITDA for the year ended 31 December 2025, based on unaudited figures. Revenue has grown at a compound annual rate of approximately 9% since 2023, with the business moving from loss to profit. The North American technical roll foam market is estimated by Zotefoams to exceed US$140m, growing at 4% to 6% annually. The group claims organic replication would require US$20m and five years, suggesting the acquisition is capital-efficient. The deferred consideration and management incentive are tied to customer retention and growth plan delivery, but no specific thresholds are disclosed. The company expects a positive EBITDA contribution in the first full year and earnings accretion from the second, but quantifies neither. The modest expected revenue impact in 2026 and unchanged group guidance indicate limited immediate financial upside.

Analysis

The announcement is generally positive in tone and provides concrete, realised facts: the acquisition of Verttec LLC is completed, with full financial terms disclosed, including staged consideration and funding sources. Verttec's recent revenue and EBITDA are stated, and the business has moved from loss to profit, supporting a positive operational trajectory. However, several key claims are forward-looking, such as the expected positive contribution to Group EBITDA and earnings accretion, with no quantified forecasts or pro forma impact provided. Market size and growth rates are presented as company estimates without external validation. The narrative emphasizes strategic benefits and cost avoidance (US$20m, five years to replicate), but the actual near-term financial impact is described as 'very modest,' and Group expectations remain unchanged. The absence of detailed, audited, or pro forma profitability metrics for the combined group, and the lack of specific thresholds for the earn-out, limit the strength of the investment signal. The language is somewhat promotional in comparing the acquisition to a hypothetical, more expensive organic build, but this is balanced by the modest near-term expectations.

Risk flags

• ●Verttec’s reported financials are unaudited, raising uncertainty about the reliability of the US$5.1m revenue and US$0.3m EBITDA figures. If actual results differ materially, the acquisition’s value proposition could weaken.
• ●Deferred consideration and management incentives are contingent on revenue retention and growth, but the specific performance criteria are undisclosed. This lack of transparency makes it difficult to assess the likelihood of full earn-out payment or management retention.
• ●The North American roll foam market size (US$140m) and growth rates (4%–6%) are company estimates without external validation. If the market is smaller or less dynamic, growth assumptions may prove optimistic.
• ●The expected positive EBITDA contribution and earnings accretion are forward-looking and not quantified. Integration risks, customer retention, or operational challenges could delay or reduce these benefits.
• ●The acquisition is expected to make only a modest contribution to 2026 revenue, with group guidance unchanged. This suggests limited short-term upside and a reliance on longer-term execution for value realisation.

Bottom line

Zotefoams’ acquisition of Verttec adds a new US-based crosslinked roll foam capability at a price of up to US$7.3m, with US$5.1m paid upfront and the rest contingent on performance. Verttec brings US$5.1m in unaudited 2025 revenue and US$0.3m EBITDA, with recent growth but a small scale relative to Zotefoams’ broader business. The acquisition is positioned as a cost- and time-efficient alternative to organic build-out, but immediate financial impact is modest and group guidance is unchanged. Key risks include the unaudited nature of Verttec’s financials, lack of detail on earn-out triggers, and unverified market size claims. The main takeaway is that this deal is a strategic platform move for Zotefoams in North America, with near-term upside limited and longer-term value dependent on successful integration and market growth. Investors should watch for updates on Verttec’s performance against earn-out criteria and any further investment in the Pennsylvania facility.

Announcement summary

(LSE:ZTF) Zotefoams plc has acquired Verttec LLC, a manufacturer of technical roll foams based in East Greenville, Pennsylvania, USA, for total consideration of up to US$7.3m. The acquisition was made through Zotefoams US Holdings Inc., a newly incorporated wholly owned subsidiary, and includes an initial consideration of US$5.1m, subject to customary adjustments, with up to a further US$2.2m payable over 24 months based on revenue performance and other criteria. The acquisition was funded from Zotefoams' existing cash resources and debt facilities. Verttec adds specialist crosslinked roll foam capability to Zotefoams, distinct from the Group’s non-crosslinked and block foams produced at OKC in Spain and block foams manufactured in the UK, US, and Poland. Zotefoams estimates that organic investment to replicate Verttec would cost approximately US$20m and take five years. Verttec’s plant in Pennsylvania has two extrusion lines with capacity to support several times the current production volume. For the financial year ended 31 December 2025, Verttec generated revenue of US$5.1m and adjusted EBITDA of US$0.3m, based on unaudited financial information. Verttec’s revenue has grown at a compound annual rate of approximately 9% since 2023, with the business moving from loss to profit over that period. The North American technical roll foam market is estimated by Zotefoams to exceed US$140m and is growing at 4% to 6% annually. The acquisition is expected to contribute positively to Group EBITDA in its first full year of ownership and to be earnings accretive from the second full year. The acquisition is expected to make a very modest contribution to Group revenue in the financial year ending 31 December 2026, and the Group’s full-year expectations remain unchanged. Verttec will continue to operate from its existing facility under the leadership of Ryan Dempsey, who has entered into a new employment agreement and will report to the Group’s North American management. The deferred consideration is contingent on the retention of Verttec’s existing customer revenue and on the delivery of its growth plan, and includes a management incentive for Ryan Dempsey, payable after 24 months and conditional on his continued employment and other performance criteria. At its Capital Markets Day in March 2025, Zotefoams set out a strategy to expand beyond its core business through organic growth and selective M&A, with medium-term targets of more than £300m in revenue and £60m in operating profit. The acquisition of Verttec represents the first acquisition in the development of the Group’s North American platform. Verttec’s Pennsylvania plant complements Zotefoams’ existing facilities in Kentucky and Oklahoma, USA. The Group will assess further investment in the site, including bringing irradiation in-house. Ronan Cox, Group CEO of Zotefoams, stated that Verttec adds a valuable capability the Group did not previously have and provides a quicker, more cost-effective, and lower-risk route than building this capability internally. Ryan Dempsey, President of Verttec, commented that joining Zotefoams opens new opportunities for growth and customer development across North America.

Disagree with this article?